CareCloud, Inc. (CCLD) Stock Analysis

Company Overview

CareCloud, Inc. operates as a healthcare information technology company that provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals, with a primary focus on the United States market. The company functions within the Healthcare sector and specifically serves the Health Information Services industry, positioning it as a provider of essential digital infrastructure for medical entities. This organization employs a workforce of 3,650 individuals and carries a market capitalization of $158.07 million. With an annual revenue of $120.50 million, these valuation and revenue figures indicate that the company maintains a mid-cap profile, suggesting a business that has established a significant operational footprint while retaining the potential for expansion within the specialized healthcare IT landscape.

Financial Health

The company reported a trailing twelve-month revenue of $120.50 million and generated a net income of $3.89 million, supported by an EBITDA of $16.39 million. The substantial gap between the $120.50 million in revenue and the $3.89 million in net income reveals a cost structure where non-operating expenses, such as interest, taxes, and other general administrative costs, consume a significant portion of the gross earnings before reaching the bottom line. The business generated $18.23 million in free cash flow, which provides a strong indicator of financial flexibility and the ability to fund operations, repay debt, or pursue strategic investments without relying heavily on external financing. Profitability is reflected across three key margins: a gross margin of 46.5%, an operating margin of 9.1%, and a profit margin of 9.0%, indicating that the company retains roughly 9 cents of profit for every dollar of sales after covering all costs. Regarding liquidity and leverage, the company holds $3.12 million in cash against $4.28 million in debt, resulting in a debt-to-equity ratio of 7.20, which suggests a leveraged balance sheet where debt obligations exceed available liquid cash reserves. Short-term liquidity is assessed via a current ratio of 1.05, indicating that the company's current assets slightly exceed its current liabilities, though the margin for error is narrow. Management effectiveness is further highlighted by a return on equity of 19.8% and a return on assets of 9.0%, demonstrating that the company generates substantial returns relative to the shareholder equity invested and maintains efficient asset utilization.

Valuation Assessment

Valuation metrics for CareCloud, Inc. include a trailing P/E ratio of 37.20 and a forward P/E ratio of 9.79, where the significant disparity between these figures implies that the market expects earnings to grow substantially in the future to justify the current high multiple. The price-to-book ratio stands at 2.65, indicating that the market values the company at a premium of 165% over its net book value, which often reflects intangible assets or future growth potential not captured on the balance sheet. Alternative valuation measures such as a price-to-sales ratio of 1.31 and an EV/EBITDA of 9.72 provide context that the stock is priced at roughly 1.3 times its annual sales while generating earnings before interest, taxes, depreciation, and amortization at a multiple of 9.72 times. Price momentum is defined by a 52-week high of $4.01 and a 52-week low of $1.14, and without a specific current price provided in the data, the stock's position relative to this range remains undefined by the available facts alone. The stock exhibits a beta of 2.15, which signifies that the share price is historically 2.15 times more volatile than the broader market, exposing investors to higher fluctuations during periods of market stress or stability.

Growth & Income

Revenue growth stands at 21.9% year-over-year, while earnings growth is listed as N/A, suggesting that earnings data may be irregular or not yet available for a comparable period to calculate a standard year-over-year rate. Because earnings growth is not explicitly quantified against the revenue growth of 21.9%, it is not possible to definitively state whether earnings are growing faster or slower than revenue based solely on the provided figures. The company does not pay a dividend, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means the organization reinvests all of its earnings into business growth rather than distributing cash to shareholders. The overall growth and income profile is characterized by double-digit revenue expansion and a lack of dividend distribution, focusing entirely on capital appreciation and operational scaling within the healthcare technology sector.